Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Dividends payables (2019 - 2026)

Pharma-Bio Serv's Dividends payables history spans 3 years, with the latest figure at $1.7 million for Q1 2026.

  • For Q1 2026, Dividends payables changed N/A year-over-year to $1.7 million; the TTM value through Jan 2026 reached $1.7 million, changed N/A, while the annual FY2019 figure was $1.7 million, N/A changed from the prior year.
  • Dividends payables reached $1.7 million in Q1 2026 per PBSV's latest filing, down from $1.7 million in the prior quarter.
  • In the past five years, Dividends payables ranged from a high of $1.7 million in Q1 2026 to a low of $1.7 million in Q1 2026.